Human growth hormone use in poor ovarian response–caution and opportunities

RJ Norman, RJ Hart - Therapeutic advances in reproductive …, 2021 - journals.sagepub.com
Human growth hormone has found favour as a co-gonadotrophin in assisted reproduction
particularly in the circumstances of a poor response to stimulation. Its use has been based …

[HTML][HTML] The effects of flexible short protocol with gonadotropin-releasing hormone antagonist on preventing premature ovulation in poor responders

Y Zhang, H Wang, X Zhang, Y Hao, J Yang, Y Li… - Archives of Gynecology …, 2024 - Springer
Purpose The proportion of patients with poor ovarian response (POR) is increasing, but
effective treatment remains a challenge. To control the hidden peaks of luteinizing hormone …

Exogenous insulin-like growth factor 1 accelerates growth and maturation of follicles in human cortical xenografts and increases ovarian output in mice

L Man, NL Guahmich, E Kallinos, L Park, B Caiazza… - F&S Science, 2021 - Elsevier
Objective To measure the influence of exogenous insulin-like growth factor 1 (IGF1) on
follicle growth and maturation in human ovarian cortical xenografts. Design …

[引用][C] Materials and methods Protocol registration

NOSNO Scale - Scientific Reports, 2024

[HTML][HTML] The Impact of Growth Hormone Co-Treatment Duration on Outcomes in IVF/ICSI Cycles Among Poor Ovarian Responders

Z Mohammadshirazi, A Alyasin… - … of Reproduction & …, 2023 - ncbi.nlm.nih.gov
Background: The efficiency of in vitro fertilization is improved by growth hormone (GH)
during ovarian stimulation. Additionally, patients with diabetes experience impaired insulin …

Growth Hormone Administration to Improve Reproductive Outcomes in Women with Recurrent Implantation Failure (RIF): a Systematic Review

M Vera-Montoya, J Andrés Calvache, S Geber - Reproductive Sciences, 2023 - Springer
Recurrent implantation failure (RIF) has been used to describe embryos' failure to implant
following IVF, arising concerns about the importance of its treatment. Growth hormone (GH) …

Hormonal effects in reproductive technology with focus on diminished ovarian reserve

D Barad - Hormonal Pathology of the Uterus, 2020 - Springer
Hormonal Effects in Reproductive Technology with Focus on Diminished Ovarian Reserve |
SpringerLink Skip to main content Advertisement SpringerLink Account Menu Find a journal …

[PDF][PDF] 生长激素不同预处理方案对IVF/ICSI 临床结局的影响

王璐璐, 孙丽君, 赵贝, 熊奕文, 王云霞, 李哲… - 中国生育健康 …, 2022 - cjrh.bjmu.edu.cn
目的评价生长激素(GH) 对体外受精/卵胞浆内单精子显微注射(IVF/ICSI) 治疗中胚胎质量欠佳
患者再次助孕时的胚胎质量及助孕结局的影响. 方法通过回顾性自身前后对照, 选取2016 年1 月 …

[HTML][HTML] Ovarian stimulation in assisted reproductive technology cycles for varied patient profiles: An Indian perspective

PR Jirge, MM Patil, R Gutgutia, J Shah… - Journal of Human …, 2022 - journals.lww.com
Controlled ovarian stimulation has been an integral part of in vitro fertilisation (IVF) treatment
cycles. Availability of different gonadotropins for ovarian stimulation and gonadotropin …

[HTML][HTML] The effect of human growth hormone on endometrial growth in controlled ovarian hyperstimulation cycles

B Bavan, RM Gardner, WY Zhang… - Journal of Personalized …, 2022 - mdpi.com
This study aims to compare endometrial growth before and after the addition of human
growth hormone (hGH) in controlled ovarian hyperstimulation (COH) cycles. A 5-year …